Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial (Q40780423)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
scientific article

    Statements

    Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial (English)
    Michael Manns
    Didier Samuel
    Edward J Gane
    David Mutimer
    Martín Prieto
    José Luis Calleja
    Beat Müllhaupt
    Kosh Agarwal
    Peter Angus
    Eric M Yoshida
    Massimo Colombo
    Hadas Dvory-Sobol
    Jill Denning
    Sarah Arterburn
    Phillip S Pang
    Diana Brainard
    John G McHutchison
    Jean-François Dufour
    Hans Van Vlierberghe
    Bart van Hoek
    Xavier Forns
    SOLAR-2 investigators
    18 February 2016
    685-697

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit